دورية أكاديمية
Survival and Side Effects of Cisplatin/Cyclophosphamide and Carboplatin/Paclitaxel Adjuvant Chemotherapy in Stage IC-IV Ovarian Cancer
| العنوان: | Survival and Side Effects of Cisplatin/Cyclophosphamide and Carboplatin/Paclitaxel Adjuvant Chemotherapy in Stage IC-IV Ovarian Cancer |
|---|---|
| المؤلفون: | Unedo H Markus, Hariyono Winarto, Andrijono Andrijono, Bambang Sutrisna |
| المصدر: | Indonesian Journal of Obstetrics and Gynecology, Pp 110-116 (2015) |
| بيانات النشر: | Indonesian Society of Obstetrics and Gynecology |
| سنة النشر: | 2015 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | Gynecology and obstetrics, RG1-991 |
| الوصف: | Objective: To compare the survival and side effects in epithelial ovarian cancer patients receiving adjuvant chemotherapy of cisplatin/ cyclophosphamide and carboplatin/paclitaxel. Method: We recruited epithelial ovarian cancer patients receiving cisplatin/cyclophosphamide (group A) or carboplatin/paclitaxel (group B) adjuvant chemotherapy after surgery. Chemotherapy was given for six cycles. Overall survival and side effects were assessed. Result: A total of 49 patients were recruited, consisting of 25 patients for group A and 24 patients for group B. In this study, the overall survival of stage IC-IV ovarian cancer patients was 37.3 months in group A (95%CI=31.86-43.46) and 35.5 months (95%CI= 13.93- 43.46) in group B (p |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2338-6401 2338-7335 |
| العلاقة: | http://inajog.com/index.php/journal/article/view/37Test; https://doaj.org/toc/2338-6401Test; https://doaj.org/toc/2338-7335Test; https://doaj.org/article/518b211b2352400dac4e7383eaa34959Test |
| DOI: | 10.32771/inajog.v3i2.37 |
| الإتاحة: | https://doi.org/10.32771/inajog.v3i2.37Test https://doaj.org/article/518b211b2352400dac4e7383eaa34959Test |
| رقم الانضمام: | edsbas.87B3C560 |
| قاعدة البيانات: | BASE |
| تدمد: | 23386401 23387335 |
|---|---|
| DOI: | 10.32771/inajog.v3i2.37 |